PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Gupta A, Pal SK, Pandey D, Fakir NA, Rathod S, Sinha D, SivaKumar S, Sinha P, Periera M, Balgam S, Sekar G, UmaDevi KR, Anupurba S, Nema V.
Gupta A, et al. Among authors: sinha p, sinha d.
Ann Clin Microbiol Antimicrob. 2017 Aug 18;16(1):56. doi: 10.1186/s12941-017-0234-9.
Ann Clin Microbiol Antimicrob. 2017.
PMID: 28821299
Free PMC article.